The Leadership Team at Respicardia drives strategic direction and oversees the development of innovative implantable therapies. Composed of key executives, including the President, Chief Medical Officer, and VPs of Quality Assurance, Regulatory Affairs, and Research & Development, the team ensures that the company meets regulatory standards, advances research initiatives, and ultimately improves patient outcomes in respiratory and cardiovascular health.